Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $36.79 Billion, which is 66.89x above the industry average, indicating ...
Teladoc Health is a beaten-down stock with stagnant revenue, priced attractively relative to its sector. Read why I rate TDOC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback